Hermes Florez
Hermes Florez
Professor of Medicine and Public Health Sciences
Dirección de correo verificada de med.miami.edu
Título
Citado por
Citado por
Año
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
DPPR Group
N Engl J Med 346 (6), 393-403, 2002
21087*2002
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
19652*2014
Heart disease and stroke statistics—2017 update
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
10956*2017
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
DPPR Group
Lancet 374 (9702), 1677-86, 2009
25982009
The Diabetes Prevention Program (DPP): description of lifestyle intervention
DPPR Group
Diabetes Care 25 (12), 2165-2171, 2002
14092002
Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
DPPR Group
Diabetes care 29 (9), 2102-2107 29 (9), 2102-2107, 2006
1223*2006
Diabetes in older adults
MS Kirkman, VJ Briscoe, N Clark, H Florez, LB Haas, JB Halter, ES Huang, ...
Diabetes care 35 (12), 2650-2664, 2012
1215*2012
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial
DPPR Group
Annals of internal medicine 142 (8), 611-619., 2005
11242005
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
DPPR Group
N Engl J Med 355 (3), 241-250, 2006
968*2006
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
DPPR Group
Annals of internal medicine 142 (5), 323-332, 2005
7712005
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions
DPPR Group
Journal of Clinical Endocrinology & Metabolism 93 (23), 4774-4779, 2008
7452008
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program
DPPR Group
Impact of intensive lifestyle and metformin therapy on cardiovascular …, 2005
695*2005
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
5712019
The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes
DPPR Group
Diabetes Care 22 (4), 623-634, 1999
5441999
Achieving weight and activity goals among diabetes prevention program lifestyle participants
DPPR Group
Obesity Research 12 (9), 1426-1434, 2004
5342004
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
DPPR Group
Diabetes 54 (4), 1150-1156, 2005
5202005
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin
DPPR Group
Diabetes 54 (8), 2404-2414, 2005
4622005
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
DPPR Group
Diabetes Care 26 (1), 36-47, 2003
4242003
Diabetes in older adults: consensus report
MS Kirkman, VJ Briscoe, N Clark, H Florez, LB Haas, JB Halter, ES Huang, ...
Journal of the American Geriatrics Society 60 (12), 2342, 2012
4032012
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
DPPR Group
The Lancet 379 (9833), 2243-2251, 2012
3802012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20